Article Versions Notes

Nakai K, Segawa H, Yashiro M, Yoshii K, Kusaba T, Matoba S, Tamagaki K, Hatta T, Kado H. Cystatin C-Based eGFR Predicts Post-Treatment Kidney Prognosis in Patients with Severe Obstructive Nephropathy. Kidney and Dialysis. 2022; 2(3):474-481. https://doi.org/10.3390/kidneydial2030043

Nakai, Kunihiro, Hiroyoshi Segawa, Masatomo Yashiro, Kengo Yoshii, Tetsuro Kusaba, Satoaki Matoba, Keiichi Tamagaki, Tsuguru Hatta, and Hiroshi Kado. 2022. "Cystatin C-Based eGFR Predicts Post-Treatment Kidney Prognosis in Patients with Severe Obstructive Nephropathy" Kidney and Dialysis 2, no. 3: 474-481. https://doi.org/10.3390/kidneydial2030043

Nakai, K., Segawa, H., Yashiro, M., Yoshii, K., Kusaba, T., Matoba, S., Tamagaki, K., Hatta, T., & Kado, H. (2022). Cystatin C-Based eGFR Predicts Post-Treatment Kidney Prognosis in Patients with Severe Obstructive Nephropathy. Kidney and Dialysis, 2(3), 474-481. https://doi.org/10.3390/kidneydial2030043